AnaptysBio Future Growth
Future criteria checks 2/6
AnaptysBio's earnings are forecast to decline at 0.6% per annum while its annual revenue is expected to grow at 30.6% per year. EPS is expected to grow by 5.3% per annum.
Key information
-0.6%
Earnings growth rate
5.3%
EPS growth rate
| Biotechs earnings growth | 0% |
| Revenue growth rate | 30.6% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 06 Jun 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 203 | -21 | -153 | 809 | 7 |
| 12/31/2024 | 17 | -182 | -160 | -180 | 8 |
| 12/31/2023 | 12 | -178 | -160 | -86 | 8 |
| 3/31/2023 | 11 | -137 | -78 | -77 | N/A |
| 12/31/2022 | 10 | -129 | -74 | -74 | N/A |
| 9/30/2022 | 4 | -135 | -88 | -88 | N/A |
| 6/30/2022 | 24 | -108 | -78 | -77 | N/A |
| 3/31/2022 | 53 | -76 | -45 | -44 | N/A |
| 12/31/2021 | 63 | -58 | -47 | -46 | N/A |
| 9/30/2021 | 122 | 8 | 15 | 17 | N/A |
| 6/30/2021 | 101 | -9 | 5 | 7 | N/A |
| 3/31/2021 | 71 | -30 | -23 | -22 | N/A |
| 12/31/2020 | 75 | -20 | -15 | -14 | N/A |
| 9/30/2020 | 18 | -74 | -68 | -68 | N/A |
| 6/30/2020 | 18 | -81 | -73 | -73 | N/A |
| 3/31/2020 | 23 | -84 | -69 | -69 | N/A |
| 12/31/2019 | 8 | -97 | -70 | -70 | N/A |
| 9/30/2019 | 5 | -94 | -67 | -66 | N/A |
| 6/30/2019 | 10 | -79 | -60 | -59 | N/A |
| 3/31/2019 | 5 | -69 | -53 | -52 | N/A |
| 12/31/2018 | 5 | -62 | -50 | -49 | N/A |
| 9/30/2018 | 8 | -52 | -42 | -41 | N/A |
| 6/30/2018 | 3 | -45 | -31 | -30 | N/A |
| 3/31/2018 | 10 | -34 | -24 | -24 | N/A |
| 12/31/2017 | 10 | -30 | -20 | -19 | N/A |
| 9/30/2017 | 10 | -27 | -20 | -20 | N/A |
| 6/30/2017 | 13 | -19 | -20 | -19 | N/A |
| 3/31/2017 | 12 | -15 | -15 | -15 | N/A |
| 12/31/2016 | 17 | -4 | N/A | -9 | N/A |
| 9/30/2016 | 18 | -4 | N/A | -6 | N/A |
| 6/30/2016 | 19 | -4 | N/A | -5 | N/A |
| 3/31/2016 | 18 | -6 | N/A | -9 | N/A |
| 12/31/2015 | 18 | -5 | N/A | -10 | N/A |
| 9/30/2015 | 17 | -2 | N/A | -6 | N/A |
| 6/30/2015 | 19 | 0 | N/A | -4 | N/A |
| 3/31/2015 | 18 | 1 | N/A | -3 | N/A |
| 12/31/2014 | 16 | 0 | N/A | 15 | N/A |
| 12/31/2013 | 5 | -6 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANAB * is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ANAB * is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ANAB * is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ANAB *'s revenue (30.6% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: ANAB *'s revenue (30.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ANAB *'s Return on Equity is forecast to be high in 3 years time